Information Provided By:
Fly News Breaks for April 28, 2016
BSX
Apr 28, 2016 | 07:26 EDT
After Boston Scientific reported stronger than expected Q1 results, SunTrust says that the company's results were "excellent." The firm thinks that the company's "top line momentum looks sustainable." It believes that the company's operational improvements are bearing fruit, as shown by its Q1 profits. SunTrust raised its price target on the name to $25 from $21 and keeps a Buy rating on the shares.